Andrzej Tykarski
Poznan University of Medical Sciences · Department oh Hypertension, Angiology and Internal Disease. University of Medical Sciences. Poznan,Poland · Department of Hypertension, Angiology and Internal Disease. Poznan University of Medical Sciences, Poland
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrzej Tykarski as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:33 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05943821 · The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular RiskPoznan University of Medical Sciences · recruiting · Cardiovascular Diseases, Uric Acid · study director
- Ph4NCT03206944 · Antiplatlet Effects of Standardized Tomato Extract in Hypertensive SubjectsBeata Krasinska · completed · Hypertension,Essential, Obesity · study director
- Ph4NCT03186742 · Reduction of Left Ventricular Hypertrophy After Eplerenone TherapyPoznan University of Medical Sciences · completed · Hypertension,Essential, Obstructive Sleep Apnea, Left Ventricular Hypertrophy · study chair
- Ph2NCT00415038 · Efficacy of Rostafuroxin in the Treatment of Essential Hypertensionsigma-tau i.f.r. S.p.A. · completed · Essential Hypertension · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:33 UTC. The ranking covers the 200 most relevant of 17 PubMed records, and a shared surname and initials can bring in a namesake. All 17 on PubMed
- Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension.Am J Cardiol · 200566 citationsRCR 1.6
- Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy.Blood Press Suppl · 200350 citationsRCR 1.5
- Effect of eplerenone on the severity of obstructive sleep apnea and arterial stiffness in patients with resistant arterial hypertension.Pol Arch Med Wewn · 201633 citationsRCR 1.4
- 27 citationsRCR 0.9
- Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients.Blood Press · 201123 citationsRCR 0.8
- 23 citationsRCR 1.0
- Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy.Blood Press Suppl · 200812 citationsRCR 0.4
- Favourable hypotensive effect after standardised tomato extract treatment in hypertensive subjects at high cardiovascular risk: a randomised controlled trial.Kardiol Pol · 201811 citationsRCR 0.8
- The impact of acetylsalicylic acid dosed at bedtime on circadian rhythms of blood pressure in the high-risk group of cardiovascular patients-a randomized, controlled trial.Eur J Clin Pharmacol · 202110 citationsRCR 0.6
- Pulse pressure responses in patients treated with Valsartan and hydrochlorothiazide combination therapy.J Int Med Res · 20037 citationsRCR 0.2